Organon: Merck’s Spinoff Has Potential But More Concrete Actions Awaited

JasonDoiy/iStock Unreleased via Getty Images
Since Organon & Co. (OGN) was born as a new listed entity after Merck’s (MRK) splitting into two separate entities, its shares have been trending downwards and this, despite being added to the S&P 500.
Data by…

Click here to view the original article.